Document text
Principal Investigator: Michael S Kay
Organization: UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH
Fiscal Year: 2020
Award: $449,404
Funding agency: National Institute of Allergy and Infectious Diseases
SARS-CoV-2, a novel coronavirus, is the causative agent of the current worldwide pandemic that has already led to over 2 million infections, 125,000 deaths, and severe economic impact. Currently no preventatives, treatments, or vaccines are available, and care is solely supportive. Additionally, the 21st century has seen the emergence of multiple lethal human coronaviruses (SARS-CoV, MERS-CoV, and now SARS- CoV-2). There is an urgent need for new options to combat this and inevitable future pandemics.
Coronaviruses infect cells using a conserved entry mechanism shared by enveloped viruses across multiple families in which two regions of the trimeric viral spike protein (HR1 and HR2) form a highly stable 6- helix bundle structure, juxtaposing the viral and cellular membranes to induce membrane fusion. Inhibiting formation of this 6-helix bundle stops viral entry and prevents infection. Our lab specializes in an innovative enantiomeric screening technology (mirror-image phage display) in concert with structure-guided design, to produce novel, synthetic, D-peptide viral entry inhibitors, including CPT31, our highly potent, broadly active HIV-1 D-peptide inhibitor that has been cleared by the FDA for clinical studies. Research by us and others on SARS, a highly related coronavirus that shares 86% identity (and 95% similarity) to SARS-CoV-2 in the spike HR1, indicate that these inhibition strategies should successfully block the current coronavirus. D-peptides (peptides composed of mirror-image D-amino acids) cannot be digested by proteases in the body and, therefore, possess significant therapeutic advantages including extended half-life, lower dosing, reduced immunogenicity (not digested for MHC presentation), and durability in protease-rich environments such as the respiratory tract.
In this one-year grant application, we will first design and synthesize SARS-CoV-2 trimeric HR1-based peptides. These peptides accurately mimic HR1 as it appears on the virus during entry and are therefore invaluable drug screening targets. We will then use these mimics as targets in mirror-image phage display to identify D-peptide inhibitors of SARS-CoV-2 that block it and future SARS-related coronaviruses.
Terms: <2019 novel coronavirus><2019-nCoV><AIDS Virus><Acquired Immune Deficiency Syndrome Virus><Acquired Immunodeficiency Syndrome Virus><Affinity><Amino Acids><Antiviral Agents><Antiviral Drugs><Antivirals><Applications Grants><Assay><Bacteriophages><Binding><Bioassay><Biologic Assays><Biological Assay><Biophysics><Caring><Cell Body><Cells><Cellular Membrane><Cellular biology><Cessation of life><Chemicals><Cholesterol><Clinical Research><Clinical Study><Closure by Ligation><CoV S protein><CoV emergence><CoV glycoprotein S><CoV spike glycoprotein><CoV spike protein><Collaborations><Complex><Coronaviridae><Coronavirus><Coronavirus glycoprotein S><Coronavirus spike protein><Death><Dose><Drug Screening><Drug Targeting><Ebola><Elements><Environment><Esteroproteases><Family><Fluorescence Polarization><Future><Goals><Grant Proposals><HCoV><HIV><HIV-1><HIV-I><HIV1><Half-Life><Human><Human Immunodeficiency Virus Type 1><Human Immunodeficiency Viruses><Human immunodeficiency virus 1><Image><Infection><Infection prevention><Institutes><LAV-HTLV-III><Lead><Libraries><Ligation><Luciferase Immunologic><Luciferases><Lymphadenopathy-Associated Virus><Lytotoxicity><MERS corona virus><MERS coronavirus><MERS virus><MERS-CoV><Measures><Membrane><Membrane Fusion><Middle East Respiratory Syndrome Corona Virus><Middle East Respiratory Syndrome Coronavirus><Middle East Respiratory Syndrome Virus><Middle East Respiratory Syndrome-CoV><Middle Eastern Respiratory Syndrome Corona virus><Middle Eastern Respiratory Syndrome Coronavirus><Middle Eastern Respiratory Syndrome Virus><Middle Eastern Respiratory Syndrome-CoV><Modern Man><Modification><Molecular Interaction><Pb element><Peptidases><Peptide Hydrolases><Peptide Synthesis><Peptides><Phage Display><Phages><Phase><Prevent infection><Preventative treatment><Preventive treatment><Process><Production><Protease Gene><Proteases><Proteinases><Proteins><Proteolytic Enzymes><Pulmonary Body System><Pulmonary Organ System><Research><Resolution><Respiratory System><Respiratory Tracts><Respiratory tract structure><SARS><SARS Virus><SARS corona virus><SARS coronavirus><SARS coronavirus disease><SARS-Associated Coronavirus><SARS-CoV><SARS-CoV disease><SARS-CoV-2><SARS-CoV2><SARS-Related Coronavirus><SARS-associated coronavirus 2><SARS-coronavirus-2><SARS-related coronavirus 2><Severe Acute Respiratory Syndrome><Severe Acute Respiratory Syndrome CoV disease><Severe Acute Respiratory Syndrome Virus><Severe Acute Respiratory Syndrome corona virus><Severe Acute Respiratory Syndrome coronavirus><Severe Acute Respiratory Syndrome coronavirus disease><Severe acute respiratory syndrome coronavirus 2><Single Crystal Diffraction><Solid><Structure><Surface Plasmon Resonance><Technology><Testing><Therapeutic><Therapeutic Index><Universities><Utah><VSV><Vaccines><Vesicular Stomatitis Virus><Vesicular stomatitis Indiana virus><Viral><Virus><Virus-HIV><Work><Wuhan coronavirus><X Ray Crystallographies><X-Ray Crystallography><X-Ray Diffraction Crystallography><X-Ray/Neutron Crystallography><Xray Crystallography><aminoacid><anti-viral agents><anti-viral drugs><anti-virals><bacterial virus><base><biophysical foundation><biophysical principles><biophysical sciences><cell biology><combat><corona virus><coronavirus S protein><coronavirus emergence><coronavirus spike glycoprotein><cytotoxicity><design><designing><drug discovery><economic impact><emergent CoV><emergent coronavirus><emerging CoV><emerging coronavirus><heavy metal Pb><heavy metal lead><human CoV><human corona virus><human coronavirus><imaging><immunogenicity><improved><inhibitor><inhibitor/antagonist><innovate><innovation><innovative><membrane structure><nCoV><new CoV><new coronavirus><novel><novel CoV><novel coronavirus><pandemic><pandemic disease><peptide aminoacid sequence><peptide sequence><protein aminoacid sequence><scaffold><scaffolding><screening><severe acute respiratory syndrome-CoV><structural biology><tool><trafficking><virus envelope>